Verastem reported $0 in Stock for its fiscal quarter ending in March of 2022.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
AstraZeneca USD 6.57B 13M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Incyte USD 115.62M 14.56M Mar/2026
Laboratory Of America USD 497.7M 37M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 129.03M 3.44M Mar/2026